Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,332 | 66,074 | 70,681 | 74,463 | 68,588 |
| Marketable Securities | 1,285 | 1,285 | 1,285 | 1,285 | 1,495 |
| Receivables | 23,491 | 33,471 | 31,295 | 25,536 | 23,986 |
| Inventories | 82,242 | 70,665 | 72,422 | 80,174 | 84,887 |
| Income taxes - deferred | N/A | N/A | 19,176 | 19,176 | 19,707 |
| TOTAL | $173,442 | $175,934 | $199,059 | $203,898 | $202,597 |
| Non-Current Assets | |||||
| PPE Net | 144,684 | 142,161 | 141,181 | 139,251 | 138,276 |
| Other Non-Current Assets | 76,880 | 72,041 | 54,787 | 55,780 | 55,629 |
| TOTAL | $221,564 | $214,202 | $195,968 | $195,031 | $193,905 |
| Total Assets | $395,006 | $390,136 | $395,027 | $398,929 | $396,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,177 | 10,934 | 14,762 | 12,632 | 12,531 |
| Accounts payable and accrued liabilities | 18,619 | 13,872 | 12,265 | 18,447 | 18,948 |
| Accrued Expenses | 30,225 | 31,430 | 40,728 | 31,051 | 30,569 |
| TOTAL | $64,921 | $59,955 | $70,653 | $69,404 | $72,090 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,092 | 30,165 | 31,354 | 34,798 | 35,886 |
| Deferred Revenues | 643 | 643 | 643 | 4,367 | 6,886 |
| Other Non-Current Liabilities | 3,229 | 3,167 | 1,896 | 1,963 | 1,585 |
| TOTAL | $33,500 | $34,671 | $40,588 | $44,260 | $45,131 |
| Total Liabilities | $98,421 | $94,626 | $111,241 | $113,664 | $117,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,846 | 44,914 | 45,020 | 45,337 | 44,724 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | 62,812 | 60,323 | 52,790 | 55,798 | 62,445 |
| Other shareholders' equity | -1,915 | -2,647 | -3,754 | -4,194 | -4,481 |
| TOTAL | $296,585 | $295,510 | $283,786 | $285,265 | $279,281 |
| Total Liabilities And Equity | $395,006 | $390,136 | $395,027 | $398,929 | $396,502 |